To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Virtual screeningVirtual screening ("VS") has become an integral part of the drug discovery process in recent years. Related to the more general and long pursued concept of database searching, the term "virtual screening" is relatively new. Walters, et al. define virtual screening as "automatically evaluating very large libraries of compounds" using computer programs.[1] As this definition suggests, VS has largely been a numbers game focusing on questions like how can we filter down the enormous chemical space of over 1060 conceivable compounds[citation needed] to a manageable number that can be synthesized, purchased, and tested. Although filtering the entire chemical universe might be a fascinating question, more practical VS scenarios focus on designing and optimizing targeted combinatorial libraries and enriching libraries of available compounds from in-house compound repositories or vendor offerings. Additional recommended knowledgeThe main goal of a virtual screen is to come up with hits of novel chemical structure that yield a unique pharmacological profile. Thus, success of a virtual screen is defined in terms of finding interesting new scaffolds rather than many hits. Interpretations of VS accuracy should therefore be considered with caution. Low hit rates of interesting scaffolds are clearly preferable over high hit rates of already known scaffolds. See also
References
Further reading
Categories: Medical research | Bioinformatics | Pharmacology |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Virtual_screening". A list of authors is available in Wikipedia. |